Macrolides in Chronic Inflammatory Skin Disorders
Long-term therapy with the macrolide antibiotic erythromycin was shown to alter the clinical course of diffuse panbronchiolitis in the late 1980s. Since that time, macrolides have been found to have a large number of anti-inflammatory properties in addition to being antimicrobials. These observation...
Saved in:
Main Authors: | Abdullateef A. Alzolibani, Khaled Zedan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2012/159354 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
by: Carmen Rodriguez-Cerdeira, et al.
Published: (2012-01-01) -
Future Uses of Newer Macrolides
by: John Segreti
Published: (1993-01-01) -
Suppressive Activity of a Macrolide Antibiotic, Roxithromycin, on Pro-Inflammatory Cytokine Production in Vitro and in Vivo
by: H. Suzaki, et al.
Published: (1999-01-01) -
In Vitro Activity of New Macrolides against Respiratory Pathogens
by: Michel G Bergeron
Published: (1993-01-01) -
Candida albicans and Napkin Dermatitis: Relationship and Lesion Severity Correlation
by: Amani Hussein Karsani, et al.
Published: (2017-09-01)